Top Stock Reports for Gilead, Oracle & Morgan Stanley
Henry Schein's (HSIC) MicroMD receives ONC-Health IT Certificate from Drummond Group, boosting the company's technology and value-added service business.
On Jun 28, we issued an updated research report on California-based Abaxis, Inc. (ABAX).
DENTSPLY SIRONA Inc. (XRAY), a dental solutions company, recently announced the renewal of an existing distribution agreement with Henry Schein Canada, Inc.
Over the last six months, Henry Schein Inc. (HSIC) was consistently trading ahead of the S&P 500 Index.
Top Research Reports for Verizon, Alibaba & Wells Fargo
On Jun 15, we issued an updated research report on Melville, NY-based Henry Schein, Inc. (HSIC).
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
On Jun 2, we issued an updated research report on St. Paul, MN-based The Patterson Companies (PDCO), a leading distributor of the dental, companion-pet veterinarian and rehabilitation supply markets.
On May 25 2017, we issued an updated research report on Melville, NY-based Henry Schein, Inc. (HSIC).
New Stock Research Reports for Merck, 3M and United Technologies
Pure Storage Inc. (PSTG) reported non-GAAP loss (including stock-based compensation) of 30 cents per share in the first-quarter of fiscal 2018, which was narrower than the Zacks Consensus Estimate by 8 cents.
Henry Schein, Inc. (HSIC) reported adjusted earnings per share (EPS) of $1.76 in the first quarter of 2017, up 24.8% year over year.
Headquartered in Melville, NY, Henry Schein Inc. (HSIC) is a global leading provider of healthcare products and services.
Medical product, an important part of the medical device subcategory within the broader Medical sector, looks promising at the moment.
Henry Schein, Inc. (HSIC) is expected to report first-quarter 2017 results on May 2, before the opening bell.
On Mar 27, we issued an updated research report on Melville, NY-based Henry Schein, Inc. (HSIC).
Henry Schein, Inc. (HSIC) recently signed an exclusive distribution agreement with patient care platform designer Rijuven Corp. to sell the latter's CardioSleeve device